To sum up, we identified EIF4A3-mediated circPRKCI expression acts as a tumor-promoter in TNBC through regulating WBP2 and PI3K/AKT signaling pathway via serving as miR-545-3p sponge, providing a novel providing a new avenue of therapy for TNBC. This evidence concerns the gene EIF4A3 and neoplasm.